Contracts › 75F40123C00199
75F40123C00199: Leveraging Real-World Data (RWD) to Investigate the Natural History of Rare Cancers Treated in the Us Community Oncology Setting to Provide Clinical Context to Inform Future Research
Awarded to Mckesson Specialty Health Pharmaceutical & Biotech Solutions Llc by Food and Drug Administration (FDA).
$2.9Mobligated
$2.9Mpotential value
29 September 2028current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75F40123C00199 |
|---|---|
| Awardee | Mckesson Specialty Health Pharmaceutical & Biotech Solutions Llc |
| Awarding agency | Food and Drug Administration (FDA) |
| Awarding office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541720 Research and Development in the Social Sciences and Humanities |
| PSC | B529 Special Studies/Analysis- Scientific Data |
| Place of performance | TX |
| Offers received | 1 |
| Period of performance | 20 September 2023 to 29 September 2028 |
| Potential end | 29 September 2028 |
| Estimated recompete solicitation | ~Q2 2028 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541720 contracts · All expiring contracts · USASpending record